DUSTY MEEKS: Open Payments
NPI 1538412275 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 42 payments from 14 companies in 2025. Trend: 2023 $611 · 2024 $1,222 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 20 | $235 |
| ABBVIE INC. | 6 | $106 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Verona Pharma, Inc. | 1 | $27 |
| Antares Pharma, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
Products named: Azstarys, LINZESS, REXULTI, JARDIANCE, BREZTRI, GEMTESA, Ohtuvayre, XYOSTED.
Industry payments across TX — which companies pay providers there.
